Quartalsergebnisse (Earnings) für Johnson & Johnson

zacks.com2026-08-21 12:46:18

Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update

JNJ's MONARCH QUEST 3 wins FDA 510(k) clearance, adding AI-powered planning, navigation and imaging upgrades for robotic bronchoscopy.

zacks.com2026-08-21 09:31:12

Merck vs. J&J: Which Healthcare Giant Should Investors Choose?

JNJ's diversified portfolio and pipeline strength offer an edge over MRK as both face patent expiration challenges.

zacks.com2026-08-20 18:46:07

Johnson & Johnson (JNJ) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest trading session, Johnson & Johnson (JNJ) closed at $267.37, marking a -2.21% move from the previous day.

fool.com2026-08-20 17:14:01

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.

247wallst.com2026-08-20 11:40:27

VYM Is Beating the S&P 500 With a 17% Year-to-Date Return by Owning What Wall Street Won’t

A mechanical yield screen is quietly outpacing the S&P 500 this year by excluding most of the AI complex before a single share is purchased, and the valuation gap it creates raises a question worth answering before the rotation reverses.

fool.com2026-08-20 10:52:00

Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future

Johnson and Johnson's new drugs may offset declining sales due to patent-protection losses.

247wallst.com2026-08-20 10:40:31

Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO

Seaport Therapeutics just went public with a prodrug platform that has attracted board members from two of the biggest neuroscience acquisitions in recent history. The question is whether the same giants who funded those deals are already circling for a third.

defenseworld.net2026-08-20 05:15:36

Empire Life Investments Inc. Sells 7,004 Shares of Johnson & Johnson $JNJ

Empire Life Investments Inc. reduced its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 144,822 shares of the company's stock after selling 7,004 shares during the period. Johnson and Johnson comprises

defenseworld.net2026-08-20 05:15:28

Fairway Wealth LLC Reduces Stock Position in Johnson & Johnson $JNJ

Fairway Wealth LLC cut its position in Johnson and Johnson (NYSE: JNJ) by 96.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 105 shares of the company's stock after selling 3,334 shares during the period. Fairway Wealth LLC's holdings in Johnson and Johnson

defenseworld.net2026-08-20 04:39:42

Johnson & Johnson $JNJ Stock Holdings Decreased by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC decreased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 37.9% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,438 shares of the company's stock after selling 2,706 shares during the period. Catalyst Capital Advisors LLC's holdings

EPS (USD)

Umsatz (USD)

Revisionen der Gewinnschätzungen